Skip to main content
13/07/2018 - 13:53

Mitchell secures European cannabis licence

13/07/2018 - 13:53

Bookmark

Save articles for future reference.

MGC Pharmaceuticals’ manufacturing facility in Slovenia will now commence production of pharmaceutical grade cannabis derived medicines after receiving a manufacturing licence. The Brett Mitchell chaired company will now begin full scale manufacturing of its epilepsy drug CannEpil for final, independent validation before exportation into Australasia and Europe. CannEpil is already approved for use in Australia.

X